SCHEMBL6423690

SCHEMBL6423690

CC1CC2OC(=O)C(C)C2C(O)C2(C)C(=O)C=CC12

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAPT P10636 8/20 0.58
▸ RAB9A P51151 6/20 0.58
▸ NPC1 O15118 5/20 0.58
▸ HTT P42858 5/20 0.58
▸ POLB P06746 4/20 0.58
▸ XBP1 P17861 4/20 0.58
▸ MDM2 Q00987 4/20 0.58
▸ MAPK1 P28482 3/20 0.58
▸ AGTR1 P30556 3/20 0.58
▸ GPR55 Q9Y2T6 3/20 0.58
▸ TERT O14746 1/20 0.58
▸ ALDH1A1 P00352 1/20 0.58
▸ GLA P06280 1/20 0.58
▸ SMN1; SMN2 Q16637 1/20 0.58
▸ TDP1 Q9NUW8 1/20 0.58
▸ PTGS2 P35354 1/20 0.52
▸ ATM Q13315 1/20 0.52
▸ PAX8 Q06710 1/20 0.47
▸ RECQL P46063 4/20 0.46
▸ THRB P10828 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30899614 1.00 MAPT (0.58) MAPTRAB9ANPC1HTTPOLB
SCHEMBL30151485 1.00 MAPT (0.58) MAPTRAB9ANPC1HTTPOLB
SCHEMBL30555815 0.83 MAPT (0.64) MAPTRAB9ANPC1HTTPOLB
SCHEMBL27014677 0.81 MAPT (0.51) MAPTRAB9ANPC1HTTPOLB
SCHEMBL25363305 0.81 MAPT (0.51) MAPTRAB9ANPC1HTTPOLB
Brevilin A SCHEMBL27014670 0.80 MAPT (0.52) MAPTRAB9ANPC1HTTPOLB
SCHEMBL27014666 0.80 MAPT (0.55) MAPTRAB9ANPC1HTTPOLB
Brevilin A SCHEMBL27014668 0.80 MAPT (0.52) MAPTRAB9ANPC1HTTPOLB
SCHEMBL9975665 0.78 MAPT (0.48) MAPTRAB9ANPC1HTTPOLB
SCHEMBL27014729 0.78 MAPT (0.51) MAPTRAB9ANPC1HTTPOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998038971-A1 THERAPEUTIC COMPOSITION AND METHOD FOR TREATING SKIN USING CENTIPEDA CUNNINGHAMI EXTRACT BIO-BOTANICA, INC. (US) 1998-09-11 — — WO claimed
US-5804206-A PROVIDING PLANT MATERIAL OF CENTIPEDA GENUS IN POWDER FORM, SEQUENTIALLY MACERATING AND EXTRACTING WITH PLURALITY OF AQUEOUS/ETHANOLIC SOLVENTS OF DIFFERENT CONCENTRATION, COMBINING SOLUTIONS BIO-BOTANICA, INC. (US) 1998-09-08 — — US claimed
CN-108743583-A Application of the sesquiterpene lactone chemical combination object in preparing the drug with antivirus action in Centipeda minima 暨南大学 2018-11-06 — — CN disclosed
CN-104771393-B Application of sesquiterpene lactone compounds in preparation of anti-influenza virus drugs 暨南大学 2017-06-23 — — CN disclosed
CN-104771393-A Application of sesquiterpene lactone compounds in preparation of anti-influenza virus drugs UNIV JINAN 2015-07-15 — — CN disclosed
EP-1509181-A1 PERSONAL CARE ARTICLE AND METHOD FOR INHIBITING ATTACHMENT OF YEAST TO SKIN Kimberly-Clark Worldwide, Inc. (US) 2005-03-02 — — EP disclosed
WO-2004112819-A1 COMPOSITIONS AND METHODS OF TREATMENT COMPRISING PLANT EXTRACTS GELSTAT CORPORATION (US) 2004-12-29 — — WO disclosed
WO-2003101356-A1 PERSONAL CARE ARTICLE AND METHOD FOR INHIBITING ATTACHMENT OF YEAST TO SKIN KIMBERLY-CLARK WORLDWIDE, INC. (US) 2003-12-11 — — WO disclosed
US-20030224034-A1 Personal care article and method for inhibiting attachment of yeast to skin KIMBERLY-CLARK WORLDWIDE, INC. 2003-12-04 — — US disclosed
WO-1998038971-A1 THERAPEUTIC COMPOSITION AND METHOD FOR TREATING SKIN USING CENTIPEDA CUNNINGHAMI EXTRACT BIO-BOTANICA, INC. (US) 1998-09-11 — — WO disclosed
US-5804206-A PROVIDING PLANT MATERIAL OF CENTIPEDA GENUS IN POWDER FORM, SEQUENTIALLY MACERATING AND EXTRACTING WITH PLURALITY OF AQUEOUS/ETHANOLIC SOLVENTS OF DIFFERENT CONCENTRATION, COMBINING SOLUTIONS BIO-BOTANICA, INC. (US) 1998-09-08 — — US disclosed
US-5663196-A ADMINISTERING A SESQUITERPENE LACTONE TO AN ANIMAL BOSTON UNIVERSITY (US) 1997-09-02 — — US disclosed
WO-1995006476-A1 METHODS AND COMPOSITIONS FOR TREATING NEOPLASTIC DISORDERS TRUSTEES OF BOSTON UNIVERSITY (US) 1995-03-09 — — WO disclosed
Send feedback